450 russians with rare muscle disease to be tracked in real-world treatment study

NCT ID NCT07247279

First seen Jan 04, 2026

Summary

This study watches how doctors in Russia treat adults with a rare muscle-weakening disease called generalized myasthenia gravis (gMG). It does not test any new drug. Instead, it collects information from medical records and routine check-ups for about 450 people over time. The goal is to understand which treatments are used and how patients do in everyday practice.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RARE DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Research Site

    RECRUITING

    Kazan', Russia

  • Research Site

    RECRUITING

    Moscow, Russia

  • Research Site

    RECRUITING

    Novosibirsk, Russia

  • Research Site

    RECRUITING

    Rostov-on-Don, Russia

  • Research Site

    NOT_YET_RECRUITING

    Saint Petersburg, Russia

  • Research Site

    RECRUITING

    Samara, Russia

Conditions

The condition(s) this trial relates to.

myasthenia gravis Rare Diseases

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.